Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals

AIDS

Volumn 31, Issue 10, 2017, Pages 1471-1481

  Langebeek, Nienke ^a,b   Kooij, Katherine W ^b   Wit, Ferdinand W ^b,c   Stolte, Ineke G ^c   Sprangers, Mirjam A G ^b   Reiss, Peter ^b,c,d   Nieuwkerk, Pythia T ^b   Van Der Valk, M ^b   Schouten, J ^b   Van Zoest, R A ^b   Verheij, E ^b   Verboeket, S O ^b   Elsenga, B C ^b   Prins, M ^c   Van Der Loeff, M F Schim ^c   Berkel, J ^c   Totte M ^c   Kruijer, T ^c   Del Grande, L ^c   Gambier, C ^c   Visser, G R ^c   May, L ^c   Kovalev, S ^c   Newsum, A ^c   Dijkstra, M ^c   Zaheri, S ^d   Hillebregt, M M J ^d   Ruijs, Y M C ^d   Benschop, D P ^d   El Berkaoui, A ^d   Zikkenheiner, W ^b   Janssen, F R ^b   Kootstra, N A ^b   Harskamp Holwerda, A M ^b   Maurer, I ^b   Booiman, T ^b   Mangas Ruiz, M M ^b   Girigorie, A F ^b   Boeser Nunnink, B ^b   Geerlings, S E ^b   Godfried, M H ^b   Goorhuis, A ^b   Hovius, J W R ^b   Van Der Meer, J T M ^b   Nellen, F J B ^b   Van Der Poll, T ^b   Prins, J M ^b   Wiersinga, W J ^b   Van Vugt, M ^b   De Bree, G ^b   Van Eden, J ^b   Van Hes, A M H ^b   Mutschelknauss, M ^b   Nobel, H E ^b   Pijnappel, F J J ^b   Bijsterveld, M ^b   Weijsenfeld, A ^b   Smalhout, S ^b   De Jong, J ^b   Postema, P G ^b   Bisschop, P H L T ^b   Serlie, M J M ^b   Lips, P ^e   Dekker, E ^b   Van Der Velde, N ^b   Willemsen, J M R ^b   Vogt, L ^b   Portegies, P ^b   Schmand, B A ^b   Geurtsen, G J ^b   Verberne, H J ^b   De Jong, M ^b   Verbraak, F D ^b   Demirkaya, N ^b   Visser, I ^b   Schade A ^e   Van Steenwijk, R P ^b   Dijkers, E ^b   Majoie, C B L M ^b   Caan, M W A ^b   Su, T ^b   Van Lunsen, H W ^b   Nievaard, M A F ^b   Van Den Born, B J H ^b   Stroes, E S G ^b   Mulder, W M C ^f   more..

^a RIJNSTATE HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d STICHTING HIV MONITORING   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Hiv Vereniging Nederland   (Netherlands)

Author keywords

ageing; cohort study; comorbidity; depression; health related quality of life; HIV infection

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGE; AGING; ANTIRETROVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT HEALTH QUESTIONNAIRE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; AGED; COMPARATIVE STUDY; COMPLICATION; PROSPECTIVE STUDY; PSYCHOLOGY;

AGED; AGING; COMORBIDITY; DEPRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 85018493347     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001511     Document Type: Article

References (43)

1. Palella FJ, Delaney KM, Moorman AC, Lovenless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
2. Weber R, Ruppik M, Rickenbach M, Speori A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med 2013; 14:195-207.
3. Legarth RA, Ahlström MG, Kronborg G, Larsen CS, Pedersen G, Mohey R, et al. Long-termmortality in HIV-infected individuals 50 years or older: a nationwide, population-based cohort study. J Acquir Immune Defic Syndr 2016; 71:213-218.
4. van Sighem A, Gras L, Smit C, et al. Monitoring report: human immunodeficiency virus (HIV) infection in the Netherlands. Amsterdam, The Netherlands: HIV Monitoring Foundation; 2014.
5. Miners A, Philips A, Kreif N, Rodger A, Speakman A, Fisher M, et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet 2014; 1:32-40.
6. Pedersen KK, Eiersted MR, Gaardbo JC, Pedersen M, Gerstoft J, Troseid M, et al. Lower self-reported Quality of Life in HIVinfected patients o cART and with low co-morbidity compared to healthy controls. J Acquire Immune Def Syndr 2015; 70:16-22.
7. Galvan FH, Bing EG, Fleishman JA, London AS, Caetanor R, Burnam MA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 2002; 63:179-186.
8. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58:721-728.
9. Degroote S, Vogelaers D, Vandijck DM. What determines health-related quality of life among people living with HIV: an updated review of the literature. Arch Public Health 2014; 72:40.
10. Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV Cohort Study. Clin Infect Dis 2014; 59:1787-1797.
11. Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care 2012; 25:451-458.
12. Oursler KK, Goulet J, Crystal S, Justice AC, Crothers K, Butt AA, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: Results from the Veterans Aging Cohort Study. AIDS Patient Care STDs 2011; 25:13-20.
13. Rodriguez-Penney AT, Loudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on healthrelated quality of life. AIDS Patient Care STDs 2013; 27:5-16.
14. Hays RD, Cunningham WE, Sherbourne CD, Wilson IB, Wu AW, Cleary PD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med 2000; 108:714-722.
15. Moore RC, Fazeli PL, Jeste DV, Moore DJ, Grant I, Woods SP. Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV. AIDS Behav 2014; 18:1186-1197.
16. Crystal S, Akincigil A, Sambamoorthi U, Wenger N, Fleishman JA, Zingmond DS, et al. The diverse older HIV-positive population: a national profile of economic circumstances, social support and quality of life. J Acquir Immune Defic Syndr 2003; 33:S76-S83.
17. Erlandson KM, Allshouse AA, Jankowski CM, Mawhinney S, Kohrt WM, Campbell TB. Relationship of physical function and quality of life among persons aging with HIV infection. AIDS 2014; 28:1939-1943.
18. Erlandson KM, Li X, Abraham AG, Margolick JB, Lake JE, Palella FJ, et al. Long-termimpact of HIV wasting on physical function. AIDS 2016; 30:445-454.
19. Greene M, Covinsky K, Astemborski J, Piggott DA, Brown T, Leng S, et al. The relationship of physical performance with HIV disease and mortality. AIDS 2014; 28:2711-2719.
20. Justice AC, McGinnis KA, Atkinson JH, Heaton RK, Young C, Sadek J, et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS 2004; 18:S49-59.
21. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158:725-730.
22. Lawson MA, Kelley KW, Dantzer R. Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav Immun 2011; 25:1569-1575.
23. Cassol E, Misra V, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Altered monoamine and acylcarnitine metabolites in HIVpositive and HIV-negative subjects with depression. J Acquir Immune Defic Syndr 2015; 69:18-28.
24. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston, MA: Health Institute, New England Medical Center; 1993.
25. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51:1159-1165.
26. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606-613.
27. MAPI research Institute. Dutch version of the PHQ-9. Available at: http://www.phqscreeners.com. [Accessed 6 May 2017]
28. Radloff LS. A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385e401.
29. Bouma J, Ranchor AV, Sanderman R, Van Sonderen FLP. Het meten van symptomen van depressie met de CES-D. Een handleiding. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, Rijksuniversiteit Groningen; 1995.
30. Weissman M, Sholomskas D, Pottenger M, Prusoff B, Locke B. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106:203-214.
31. Kooij KW, Wit FW, Schouten J, van der Valk M, Godfried MH, Stolte IG, et al. HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls. AIDS 2016; 30:241-250.
32. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-156.
33. Cohen J. Statistical power analysis for the behavioural sciences. Mahwah, NJ: Erlbaum; 1988.
34. Gaskin CJ, Happell B. Power, effects, confidence, and significance: an investigation of statistical practices in nursing research. Int J Nurs Stud 2014; 51:795-806.
35. Nieuwkerk P, Engelhard EAN, Smit C, Brinkman K, Geerlings SE. Health related quality of life of HIV-infected patients in care in the Netherlands: A cross-sectional assessment of patient related factors, and comparison with other chronic diseases. 10th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (abstract: P06), 22 November 2016, Amsterdam, the Netherlands.
36. Moskowitz JT, Hult JR, Bussolari C, Acree M. What works in coping with HIV? A meta-analysis with implications for coping with serious illness. Psychol Bull 2009; 135:121.
37. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol 2016; 16:22-34.
38. Elliot AJ, Chapman BP. Socioeconomic status, psychological resources, and inflammatory markers: results from the MIDUS Study. Health Psychol 2016; 35:1205-1213.
39. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 2007; 62:314-320.
40. Poudel-Tandukar K, Bertone-Johnson ER, Palmer PH, Poudel KC. C-reactive protein and depression in persons with Human Immunodeficiency Virus infection: the Positive Living with HIV (POLH) Study. Brain Behav Immun 2014; 42:89-95.
41. White JR, So Armah K, Stewart J, Gupta S, Butt AA, Gibert C, et al. Association of depressive symptoms with biomarkers in veterans with and without HIV. Conference on Retroviruses and Opportunistic Infections (abstract 714), Boston, MA, USA, February 22-25, 2016.
42. Netherlands Institute of Mental Health and Addiction, Kerncijfers druggebruik 2014, available at https://assets.trimbos.nl/docs/088c4496-ca0c-49a7-af1c-a50be922f5b1.pdf.
43. HIV Monitoring Foundation. HIV monitoring report. HIV Monitoring Foundation; 2016, Available at https://www.hiv-moni toring.nl/index.php/nederlands/. [Accessed 6 May 2017].